GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » Shiller PE Ratio

SCNX (Scienture Holdings) Shiller PE Ratio : (As of Mar. 31, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Scienture Holdings Shiller PE Ratio Historical Data

The historical data trend for Scienture Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scienture Holdings Shiller PE Ratio Chart

Scienture Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Scienture Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Scienture Holdings's Shiller PE Ratio

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Shiller PE Ratio falls into.


;
;

Scienture Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Scienture Holdings's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Scienture Holdings's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-1.34/133.0289*133.0289
=-1.340

Current CPI (Sep. 2024) = 133.0289.

Scienture Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -1.800 99.070 -2.417
201503 -0.900 99.621 -1.202
201506 -0.156 100.684 -0.206
201509 -0.356 100.392 -0.472
201512 -1.800 99.792 -2.400
201603 -0.900 100.470 -1.192
201606 -3.600 101.688 -4.710
201609 -2.700 101.861 -3.526
201612 -1.800 101.863 -2.351
201703 0.209 102.862 0.270
201706 -0.019 103.349 -0.024
201709 0.201 104.136 0.257
201712 0.480 104.011 0.614
201803 0.217 105.290 0.274
201806 0.054 106.317 0.068
201809 0.244 106.507 0.305
201812 -0.877 105.998 -1.101
201903 0.300 107.251 0.372
201906 0.150 108.070 0.185
201909 0.068 108.329 0.084
201912 -1.350 108.420 -1.656
202003 0.300 108.902 0.366
202006 -1.050 108.767 -1.284
202009 0.300 109.815 0.363
202012 -4.500 109.897 -5.447
202103 -1.200 111.754 -1.428
202106 -4.800 114.631 -5.570
202109 -2.400 115.734 -2.759
202112 -1.350 117.630 -1.527
202203 -1.800 121.301 -1.974
202206 -1.990 125.017 -2.118
202209 -0.910 125.227 -0.967
202212 -1.490 125.222 -1.583
202303 -1.010 127.348 -1.055
202306 -2.900 128.729 -2.997
202309 -4.570 129.860 -4.682
202312 -14.630 129.419 -15.038
202403 16.770 131.776 16.929
202406 -1.300 132.554 -1.305
202409 -1.340 133.029 -1.340

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Scienture Holdings  (NAS:SCNX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Scienture Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Scienture Holdings Business Description

Traded in Other Exchanges
Address
2420 Brunello Trace, Lutz, FL, USA, 33558
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Executives
A. Jeffrey Newell director 645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell director 17537 DARBY LANE, LUTZ FL 33558
Janet Huffman officer: CFO, PAO, PFO 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson director 17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings director 3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel director, 10 percent owner, officer: President 17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts director PO BOX 15012, SARASOTA FL 34277
Gary Augusta director 700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss officer: CFO 17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu director, 10 percent owner, officer: CEO 8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida director 1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope director 4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu 10 percent owner 17537 DARBY LANE, LUTZ FL 33558